3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
190
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
48
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
21
Leukemia, Myelomonocytic, Chronic
20
Leukemia, Biphenotypic, Acute
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
14
Hematologic Neoplasms
14
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Leukemia, B-Cell
3
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
27
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
Drug Therapy
10
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
venetoclax
×
1 year
×
Clear all
No trials found.